McKesson Recall Dovetails With Broader Health IT Reg Debate
This article was originally published in The Gray Sheet
Executive Summary
One of McKesson Corp.’s clinical decision support software products underwent a class I recall, but it may not have been subject to this type of FDA enforcement if legislation currently under consideration in Congress was law.
You may also be interested in...
Health IT Deregulation Bill Introduced In Senate, With Powerful Industry Backers
The PROTECT Act, which attempts to respond to some criticisms of the House SOFTWARE Act, aims to restrict FDA’s oversight of health information technology. It is backed by IBM and Verizon, among others.
Representatives Grill Shuren, Advance SOFTWARE Act
Tennessee Republican Rep. Marsha Blackburn’s SOFTWARE Act advanced to the Health Subcommittee of the House Energy & Commerce Committee Nov. 19, where representatives grilled CDRH Director Jeffrey Shuren on health information technology regulation.
Bipartisan House Bill Introduced To Curb FDA Health IT Oversight
The SOFTWARE Act, introduced in the House by Rep. Marsha Blackburn, R-Tenn., with support from House members on both sides of the aisle, attempts to redefine regulation of health information technology, and, in particular, limit FDA’s oversight to “products that pose a potential risk to human health.”